About

Superbranche is a startup developing an innovative technological platform of magnetic nanoparticles for theranostic purposes.

Today, Superbranche is beginning its industrialization phase of the synthesis of its GMP-grade nanoparticles, with the ongoing construction of a pilot plant in Sélestat. This step marks a strategic advancement in preparation for the launch of clinical trials of its flagship product, SPB-20X1, developed for the treatment of solid cancers.

The major stages of Superbranche

2009

Chemicals

First development of dendronized iron oxide nanoparticles

2015/2016

Nanomaterials

CNRS research department dedicated to dendronized iron oxide nanoparticles

2017

Nanotechnology

SPIO proof of concept, synthesis and application development

2019

Innovation

Superbranche Foundation, investment in business strategy

2025

Scale-up

Construction of a pilot plant for GMP production of SPIOs

Value created

Competitions won, patents, collaborations, publications

1 license global and exclusive exploitation

5 Patents

21.7 M€ funding

+40 publications

8 PHD

i-Lab Competition Winner

GRAND PRIX OF THE

Our team

strategic advice

Founder of Superbranche, CNRS Research Director, Doctor of Organic Chemistry and world expert in the materials chemistry-biology interface

Delphine Felder-Flesch

CEO

More than 20 years of experience in acquiring pharmaceutical projects at Sanofi, Managing Partner of Finpact, financing and partnership management

Alexandre Lemoalle

General Manager

Double graduate of the ECPM engineering course as well as a doctorate in Materials Chemistry in collaboration with D. Felder-Flesch on the synthesis and characterization of magnetic nanoparticles for medical applications.

Geoffrey Cotin

Chief Technology Officer

Doctor of Pharmacy with over 10 years of international experience in quality assurance at Eli Lily, Shanghai Jinwei Biotechnology and Rhenus.

Alexander Siri

CPO

Double graduate of a Doctorate in Pharmacy and a Doctorate in Biological and Therapeutic Chemistry with solid experience in quality assurance and GMP standards.

Anne Runser

Quality Assurance Manager

Doctor of Physical Chemistry of Materials specializing in the synthesis of nanoparticles and their characterization.

Nada Khalfaoui

Nanoparticle Production Engineer

More than 20 years of experience in administrative and financial management in France and Europe, confirmed in engineering and biotechnology companies.

Stéphane Béchot

CFO

More than 15 years of experience in optimization and formulation of organic chemistry processes applied to biotechnology, pharmacy and cosmetics.

Julien Godeau

R&D Manager in Organic Chemistry

Doctor of Biology with a specialty in neuroendocrinology and oncology, expert in in vivo studies on the small animal model and in vitro in cell biology

Laura Streit

R&D Manager for In Vivo and In Vitro Studies

Master's degree in biomolecular engineering and nanobiotechnology, experienced in the nanoparticle/cellular model interface.

Sara Jakimoska

Biological Engineer

Doctor of Biology, specializing in cell biology, 3D tumor models and molecule screening. Expertise in fluorescence imaging and flow cytometry.

Luca Dirheimer

Biological Engineer

Doctor of Cellular and Molecular Biology with over 10 years of international experience in oncology.

Cindy Weidmann

Partnership Applications Engineer

Doctor of Materials Science with expertise in the design and characterization of innovative nanobiomaterials with 6 years of experience, specialist in the chemistry-biology interface